Phosphoric Acid

Phosphoric Acid

SCHEMBL74097

O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].[O+2].[O+2].[O+2]

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SLC34A1 Q06495 1/20 0.46
LMNA P02545 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL31206823 0.94
Phosphoric Acid SCHEMBL29754243 0.94 SLC34A1 (0.42) SLC34A1LMNA
Phosphoric Acid SCHEMBL29810742 0.94 SLC34A1 (0.42) SLC34A1LMNA
Phosphoric Acid SCHEMBL31296403 0.94
Phosphoric Acid SCHEMBL31296400 0.88
Phosphoric Acid SCHEMBL31406169 0.88
Phosphoric Acid SCHEMBL9747771 0.88 MAPK1 (0.44) SLC34A1LMNA
Phosphoric Acid SCHEMBL9793239 0.88 MAPK1 (0.44) SLC34A1LMNA
Phosphoric Acid SCHEMBL4919102 0.88 MAPK1 (0.44) SLC34A1LMNA
Phosphoric Acid SCHEMBL25395731 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2629 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119132442-B Quantitative calculation method for endogenous phosphorus pollution of river basin and lake Nanjing Institute Of Environmental Sciences, Mee (CN) 2026-05-26 CN claimed
US-20260125661-A1 Compositions and Methods for Kallikrein (KLKB1) Gene Editing INTELLIA THERAPEUTICS, INC. (US) 2026-05-07 US claimed
US-20260022358-A1 Compositions and Methods for Kallikrein (KLKB1) Gene Editing INTELLIA THERAPEUTICS, INC. (US) 2026-01-22 US claimed
CN-119132442-A Quantitative calculation method for endogenous phosphorus pollution of river basin and lake 生态环境部南京环境科学研究所 2024-12-13 CN claimed
US-20240391775-A1 POLYPHOSPHATE MATERIALS SAKAMOTO JUNJI (US) 2024-11-28 US claimed
CN-118731299-A Underground water phosphorus traceability analysis method and system 水利部交通运输部国家能源局南京水利科学研究院 2024-10-01 CN claimed
CN-118681528-A Phosphate adsorption material and preparation method and application thereof 厦门大学 2024-09-24 CN claimed
CN-118150298-A Pretreatment sample preparation method for preparing phosphate oxygen isotopes in water body by in-situ enrichment material 中国科学院亚热带农业生态研究所 2024-06-07 CN claimed
US-11987599-B2 Solid support for synthesizing nucleic acid sequences and methods for making and using UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2024-05-21 US claimed
US-20230271998-A1 SOLID SUPPORT FOR SYNTHESIZING NUCLEIC ACID SEQUENCES AND METHODS FOR MAKING AND USING UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2023-08-31 US claimed
EP-0981532-A1 ACYCLOVIR DIESTER DERIVATIVES Drug Innovation & Design, Inc. (US) 2000-03-01 EP claimed
US-6031096-A Acyclovir diester derivatives DRUG INNOVATION & DESIGN, INC. (US) 2000-02-29 US claimed
WO-1998051692-A1 ACYCLOVIR DIESTER DERIVATIVES DRUG INNOVATION & DESIGN, INC. (US) 1998-11-19 WO claimed
US-5789589-A VIRICIDES DRUG INNOVATION & DESIGN, INC. (US) 1998-08-04 US claimed
EP-0549107-B1 Method for producing a polynucleotide for use in single primer amplification and phosphorothioate-containing oligonucleotides as primers in nucleic acid amplification BEHRINGWERKE AG (DE) 1997-12-29 EP claimed
WO-1997040056-A1 PRODRUGS OF ACYCLOVIR DRUG INNOVATION & DESIGN, INC. (US) 1997-10-30 WO claimed
EP-0285057-B1 Modified labeled nucleotides and polynucleotides and methods of preparing, utilizing and detecting same ENZO BIOCHEM INC (US) 1995-03-01 EP claimed
WO-1994000472-A2 TRIVALENT SYNTHESIS OF OLIGONUCLEOTIDES CONTAINING STEREOSPECIFIC ALKYLPHOSPHONATES AND ARYLPHOSPHONATES RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1994-01-06 WO claimed
EP-0549107-A1 Method for producing a polynucleotide for use in single primer amplification and phosphorothioate-containing oligonucleotides as primers in nucleic acid amplification BEHRINGWERKE Aktiengesellschaft (DE) 1993-06-30 EP claimed
EP-0285057-A2 Modified labeled nucleotides and polynucleotides and methods of preparing, utilizing and detecting same ENZO BIOCHEM, INC. (US) 1988-10-05 EP claimed